Deaths in CAR-T Immune-Therapy Trials Haunt Promising New Cancer Treatment
by from MIT Technology Review on (#23XJ1)
Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.